HIV drug shows potential to combat form of dystonia in preclinical study
A new study found that ritonavir, an FDA-approved medication to treat HIV, restored multiple brain abnormalities in a mouse model of a genetic form of dystonia. The preclinical findings, featured on the cover of August’s edition of the journal Science Translational Medicine, identified ritonavir as a drug candidate with disease-modifying…